Trend Hipertensi Maternal
DOI:
https://doi.org/10.55606/jurrike.v5i2.9101Keywords:
Antenatal Care, Geographical Disparities, Maternal Health, Maternal Hypertension, Maternal MortalityAbstract
Maternal hypertension remains one of the major contributors to maternal morbidity and mortality in Indonesia and globally. This study aimed to analyze the prevalence, mortality trends, and geographical disparities of maternal hypertension in Indonesia during the 2022–2023 period. The research employed a descriptive design using secondary data obtained from official reports of the Indonesian Ministry of Health, national health surveys, and Maternal Perinatal Death Notification (MPDN) data. Data analysis was conducted descriptively by examining prevalence rates, maternal mortality due to hypertension, regional distribution, and temporal trends across provinces in Indonesia. The findings showed a slight but consistent decline in both the prevalence and mortality rates of maternal hypertension from 2022 to 2023 in most provinces. However, significant regional disparities remained evident. Provinces in eastern Indonesia, including Papua Barat, Nusa Tenggara Timur, Maluku, and several provinces in Sulawesi and Kalimantan, consistently recorded higher prevalence and mortality rates compared to provinces in Java and Bali. Meanwhile, provinces with better healthcare infrastructure and maternal referral systems demonstrated lower mortality outcomes. The study also revealed a strong association between high prevalence and increased maternal mortality, indicating the importance of healthcare accessibility, antenatal care quality, and emergency obstetric services in reducing maternal health burdens. These findings emphasize the need for region-specific maternal health interventions, improved healthcare distribution, early detection programs, and strengthened referral systems to reduce maternal hypertension disparities and improve maternal health outcomes in Indonesia.
Downloads
References
Ananth, C. V., Keyes, K. M., & Wapner, R. J. (2013). Pre-eclampsia rates in the United States, 1980–2010: Age-period-cohort analysis. BMJ, 347, f6564. https://doi.org/10.1136/bmj.f6564
Brown, M. A., Magee, L. A., Kenny, L. C., Karumanchi, S. A., McCarthy, F. P., Saito, S., Hall, D. R., Warren, C. E., Adoyi, G., & Ishaku, S. (2018). Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations. Hypertension, 72(1), 24–43. https://doi.org/10.1161/HYPERTENSIONAHA.117.10803
Duley, L. (2009). The global impact of pre-eclampsia and eclampsia. Seminars in Perinatology, 33(3), 130–137. https://doi.org/10.1053/j.semperi.2009.02.010
Ghulmiyyah, L., & Sibai, B. (2012). Maternal mortality from preeclampsia/eclampsia. Seminars in Perinatology, 36(1), 56–59. https://doi.org/10.1053/j.semperi.2011.09.011
Hutcheon, J. A., Lisonkova, S., & Joseph, K. S. (2011). Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Practice & Research Clinical Obstetrics & Gynaecology, 25(4), 391–403. https://doi.org/10.1016/j.bpobgyn.2011.01.006
Magee, L. A., von Dadelszen, P., Stones, W., & Mathai, M. (2016). The FIGO textbook of pregnancy hypertension. Global Library of Women’s Medicine.
Mol, B. W. J., Roberts, C. T., Thangaratinam, S., Magee, L. A., de Groot, C. J. M., & Hofmeyr, G. J. (2016). Pre-eclampsia. The Lancet, 387(10022), 999–1011. https://doi.org/10.1016/S0140-6736(15)00070-7
Poon, L. C., Shennan, A., Hyett, J. A., Kapur, A., Hadar, E., Divakar, H., McAuliffe, F., da Silva Costa, F., von Dadelszen, P., McIntyre, H. D., Kihara, A. B., Di Renzo, G. C., Romero, R., D’Alton, M., Berghella, V., Nicolaides, K. H., & Hod, M. (2019). The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre‐eclampsia. International Journal of Gynecology & Obstetrics, 145(S1), 1–33. https://doi.org/10.1002/ijgo.12802
Redman, C. W., & Sargent, I. L. (2005). Latest advances in understanding preeclampsia. Science, 308(5728), 1592–1594. https://doi.org/10.1126/science.1111726
Roberts, J. M., & Hubel, C. A. (2009). The two stage model of preeclampsia: Variations on the theme. Placenta, 30(Suppl. A), S32–S37. https://doi.org/10.1016/j.placenta.2008.11.009
Say, L., Chou, D., Gemmill, A., Tunçalp, Ö., Moller, A. B., Daniels, J., Gülmezoglu, A. M., Temmerman, M., & Alkema, L. (2014). Global causes of maternal death: A WHO systematic analysis. The Lancet Global Health, 2(6), e323–e333. https://doi.org/10.1016/S2214-109X(14)70227-X
Sibai, B. M. (2003). Diagnosis and management of gestational hypertension and preeclampsia. Obstetrics & Gynecology, 102(1), 181–192. https://doi.org/10.1016/S0029-7844(03)00475-7
Steegers, E. A. P., von Dadelszen, P., Duvekot, J. J., & Pijnenborg, R. (2010). Pre-eclampsia. The Lancet, 376(9741), 631–644. https://doi.org/10.1016/S0140-6736(10)60279-6
Stevens, W., Shih, T., Incerti, D., Ton, T. G. N., Lee, H. C., Peneva, D., Macones, G. A., Sibai, B. M., & Jena, A. B. (2017). Short-term costs of preeclampsia to the United States health care system. American Journal of Obstetrics and Gynecology, 217(3), 237–248. https://doi.org/10.1016/j.ajog.2017.04.032
Umesawa, M., & Kobashi, G. (2017). Epidemiology of hypertensive disorders in pregnancy: Prevalence, risk factors, predictors and prognosis. Hypertension Research, 40(3), 213–220. https://doi.org/10.1038/hr.2016.126
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Chaneda Naela Karima, Sani Rahman Soleman, Vita Widyasari
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
